MindImmune
Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease
$5MStrategic
Role not disclosedActivity from announced rounds
Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease